XNAS · ENLV
+2.67% · +$0.1925 · Vol 98.2K
After hours · updated 16:00:00 ET
Enlivex Ltd. Ordinary Shares

Enlivex Ltd. Ordinary Shares

$7.40
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ENLV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Enlivex Ltd. Ordinary Shares
Listed since
2014
Employees
34
Country
US

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$6.86
Day high
$7.64
Day low
$6.80
Previous close
$7.21
52W high
$7.64
-3.14% from high
52W low
$0.4899
97% of range
Market cap
$8.1M
Shares out
16.8M
Volume
98.2K
VWAP
$7.25
Price history computed in-house
1W
+1302.58%
1M
+1000.21%
SMA 50 $1.19 · above
SMA 200 $1.19 · above
52W position 97%
Veridion warehouse edge

Warehouse intelligence for ENLV.

Veridion Score
49
0: Not reported1: 622: 233: 504: 795: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ENLV insider activity

Enlivex Ltd. Ordinary Shares

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ENLV.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ENLV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ENLV in this window.
Lobbying spend

ENLV lobbying filings, year to date.

Registered lobbying filings matched to Enlivex Ltd. Ordinary Shares.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ENLV in this window.
Latest news · ENLV
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ENLV.
Options
Sovereign unlock shows live options positioning for ENLV.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.